Open Access

Growth inhibitory efficacy of the nutritional herb Psoralea corylifolia in a model of triple‑negative breast cancer

  • Authors:
    • Nitin T. Telang
    • Hareesh B. Nair
    • George Y.C. Wong
  • View Affiliations

  • Published online on: July 7, 2021     https://doi.org/10.3892/ijfn.2021.18
  • Article Number: 8
  • Copyright: © Telang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Triple‑negative breast cancer (TNBC) lacks the expression of estrogen receptor‑α (ER‑α), progesterone receptor (PR) and amplified human epidermal growth factor receptor‑2 (HER‑2). Current treatments involve chemotherapy and molecular targeted therapy. These options lead to dose‑limiting systemic toxicity and acquired tumor resistance. Moreover, no drug is yet available for the secondary prevention of TNBC. Such limitations underscore a need to investigate non‑toxic testable alternatives for the secondary prevention/treatment of TNBC. The Chinese nutritional herb, Psoralea corylifolia (PC), has been shown to be effective against the MCF‑7 cell line, a cellular model for ER‑α‑positive breast cancer. The present study aimed to investigate the growth inhibitory effects of PC against TNBC using the MDA‑MB‑231 cell line. Anchorage‑independent colony formation, cell cycle progression, cellular apoptosis, RB signaling and caspase‑3/7 activity assays were performed to determine the quantitative parameters for the efficacy of PC. Treatment with PC induced a 3.5‑fold increase in the G1: S + G2/M ratio, an 11‑fold increase in the apoptotic cell number and a 149‑fold increase in caspase‑3/7 activity. PC treatment also decreased cyclin D1, CDK4/6 and p‑RB expression levels. On the whole, the data of the present study identify mechanistic leads for PC as a naturally occurring testable alternative, and validate a mechanistic approach to prioritize efficacious nontoxic herbal extracts as nutritional supplements for the secondary prevention/therapy of TNBC.
View Figures
View References

Related Articles

Copy and paste a formatted citation
x
Spandidos Publications style
Telang NT, Nair HB and Wong GY: Growth inhibitory efficacy of the nutritional herb <em>Psoralea corylifolia</em> in a model of triple‑negative breast cancer. Int J Funct Nutr 2: 8, 2021
APA
Telang, N.T., Nair, H.B., & Wong, G.Y. (2021). Growth inhibitory efficacy of the nutritional herb <em>Psoralea corylifolia</em> in a model of triple‑negative breast cancer. International Journal of Functional Nutrition, 2, 8. https://doi.org/10.3892/ijfn.2021.18
MLA
Telang, N. T., Nair, H. B., Wong, G. Y."Growth inhibitory efficacy of the nutritional herb <em>Psoralea corylifolia</em> in a model of triple‑negative breast cancer". International Journal of Functional Nutrition 2.3 (2021): 8.
Chicago
Telang, N. T., Nair, H. B., Wong, G. Y."Growth inhibitory efficacy of the nutritional herb <em>Psoralea corylifolia</em> in a model of triple‑negative breast cancer". International Journal of Functional Nutrition 2, no. 3 (2021): 8. https://doi.org/10.3892/ijfn.2021.18